Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

1.0K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Short antibiotic therapy in hospitalized pneumonia: A cohort study].

La Revue de medecine interne·2024
Same author

[A swollen thumb].

La Revue de medecine interne·2023
Same author

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs).

Oncoimmunology·2023
Same author

[Splenic dysfunction in sickle cell disease: An update].

La Revue de medecine interne·2023
Same author

[Visual and auditory hallucinations in a 80 year-old man].

La Revue de medecine interne·2022
Same author

[Contribution and limits of "OSCE", "long-case" and "global end-of-placement marking" as end-of-rotation assessment methods. Experience from two internal medicine wards].

La Revue de medecine interne·2022

Related Experiment Video

Updated: Dec 28, 2025

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.4K

[Botulism: A case report and literature review].

M Gendrot1, A Passeron1, A Michon1

  • 1Service de médecine interne, université Paris Descartes, AP-HP Centre-université de Paris, hôpital européen Georges-Pompidou, 20, rue Leblanc, 75015 Paris.

La Revue De Medecine Interne
|February 17, 2020
PubMed
Summary
This summary is machine-generated.

Botulism, a rare neurotoxin syndrome, can be life-threatening if diagnosis is delayed. Early recognition of symptoms like cranial nerve palsies and descending weakness is crucial for effective treatment.

Keywords:
Anticholinergic toxidromeBotulismBotulismeClostridium botulinumNeurotoxinNeurotoxineOculomotor paralysisParalysie oculomotriceSyndrome anticholinergique

More Related Videos

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.9K
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.7K

Related Experiment Videos

Last Updated: Dec 28, 2025

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays
12:25

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

16.4K
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
14:10

A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

Published on: November 14, 2014

8.9K
A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

5.7K

Area of Science:

  • Neurology
  • Infectious Diseases

Background:

  • Botulism is a rare but potentially fatal syndrome caused by Clostridium botulinum neurotoxins.
  • Delayed diagnosis of botulism can impede the effectiveness of specific antitoxin therapies.

Observation:

  • A case of a 26-year-old woman presenting with acute bilateral cranial neuropathies and anticholinergic syndrome without fever is detailed.
  • The patient experienced an acute onset of symptoms, including bilateral oculomotor palsy, fixed pupillary dilation, and descending weakness.

Findings:

  • The clinical presentation led to the diagnosis and confirmation of botulism.
  • Following treatment, the patient achieved a favorable outcome with substantial neurological recovery over seven weeks.

Implications:

  • Increased awareness of botulism's clinical manifestations and high index of suspicion are vital for prompt diagnosis.
  • Early diagnosis is critical as specific antitoxin treatment becomes ineffective with diagnostic delays.